Stocks to buy: Raja Venkatraman recommends three stocks for today—8 January

[ad_1] Nifty 50 on 7 January: Recap Even though there was a brief recovery on 7 January, markets still encountered notable selling pressure during attempts to bounce back, suggesting that bearish sentiments prevail. Interestingly, the volatility index (India VIX) decline indicates a reduction in participant anxiety. Considering these mixed indicators, it’s advisable to maintain a…

Read More

Can September series bring the long-awaited correction in Indian stock market? Fundamental and Technical experts answer

[ad_1] As the Indian stock market enters the September series, investors and analysts alike are closely watching whether this could finally be the month when the long-anticipated market correction occurs. With the Nifty and Sensex sitting at all-time highs, the market’s trajectory has been impressive, driven by strong domestic and global factors. Despite this historical…

Read More

In Focus: Varun Beverages announces record date for stock split; find out here

[ad_1] Shares of Varun Beverages gained attention on Monday, September 2, 2024, following the company’s announcement of the record date for its upcoming stock split. The split, approved at a 2:5 ratio during the June quarter earnings declaration, will have Thursday, September 12, 2024, as the “Record Date” to determine shareholders’ eligibility for the sub-division…

Read More

Shilpa Medicare soars over 11% to record high on positive phase 3 trial results for fatty liver drug NorUDCA

[ad_1] Shilpa Medicare shares surged over 11 percent to its record high after the company announced a successful outcome in Phase 3 studies for SMLNUD07, a drug known as NorUDCA. This medication is designed to treat patients with Nonalcoholic Fatty Liver Disease (NAFLD). Shilpa Medicare shares skyrocketed over 11 percent to reach a record high…

Read More
Back To Top